How Science Animation for Funding Helped Hemab Therapeutics Secure $157M

A few years ago, I struggled to explain what I do for a living.

“I make videos.”
“Oh, like…” – awkward pause – “…adult films?”
“No! Science animations.”
“Huh? What for?”

The conversation usually died there.

Now, when someone asks, I pull out my phone and show them a real success story: Hemab Therapeutics, who just raised $157M in Series C funding.

That’s the power for a science animation for funding.

The $157 Million Question: Why Science Animation for Funding Works

Hemab Therapeutics develops drugs that stop children with rare bleeding disorders from experiencing life-threatening hemorrhages. Brilliant science. Life-saving potential. But here’s their challenge – they need millions in funding from investors who don’t speak science.

Try explaining ‘bispecific antibodies binding Factor VII to activated platelets’ to someone with 15 minutes and a finance background. This is where science animation for funding becomes essential.

According to recent venture capital data from BioSpace, biotech companies raised $26 billion in 2024, with the largest rounds going to companies that could clearly communicate their value proposition. The difference between success and failure often comes down to how well you tell your story.

From “Huh?” to “Aha!” – The Power of Science Animation for Funding

When Hemab came to us in 2021, they faced the same challenge countless biotech companies encounter: exceptional science trapped behind incomprehensible jargon. Their mechanism of action was revolutionary, but explaining it required diving into complex molecular biology that lost investors within minutes.

We created animations that:

  • Made the invisible visible – showing exactly how their drug works at the molecular level
  • Simplified without dumbing down – maintaining scientific accuracy while ensuring accessibility
  • Connected science to patient impact – demonstrating real-world benefits investors care about

This week, they announced their $157 million Series C funding round.

Why Investors Don’t Speak Science (And What to Do About It)

The human brain processes visual information 60,000 times faster than text. When you’re explaining complex biotech mechanisms, this isn’t just a nice-to-have – it’s essential for success. Research shows that people retain 65% of visual information after three days, compared to just 10% of written information.

For biotech companies seeking funding, this creates a critical communication gap. Your investors are brilliant at evaluating market potential, competitive landscapes, and financial projections. But when it comes to understanding your science, they need help.

Science animation for funding bridges this gap by:

  • Transforming abstract concepts into concrete visuals
  • Creating emotional connections to dry scientific data
  • Enabling investors to grasp your innovation in minutes, not hours

Case Study: How Science Animation for Funding Transformed Hemab’s Pitch

Before working with us, Hemab’s pitch deck was filled with:

  • Dense scientific diagrams only PhDs could understand
  • Text-heavy slides explaining their mechanism of action
  • Static images that failed to show their drug’s dynamic process

After implementing science animation for funding:

  • Investor meetings became conversations, not lectures
  • Due diligence questions focused on business potential, not basic science
  • Their story spread organically as investors shared the animations

The result? One of 2024’s largest biotech funding rounds.

The ROI of Science Animation for Funding: Beyond Pretty Pictures

Did our animation single-handedly secure Hemab’s $157 million? Of course not. Great science, strong leadership, and market timing all played crucial roles. But here’s what effective science animation for funding does accomplish:

1. Accelerates Understanding

  • Reduces explanation time from 30 minutes to 3 minutes
  • Allows more time for strategic discussions
  • Keeps investors engaged throughout the presentation

2. Improves Retention

  • Investors remember your story weeks after the meeting
  • Makes your company stand out in a crowded field
  • Creates shareable content that extends your reach

3. Builds Confidence

  • Shows you understand the importance of clear communication
  • Demonstrates professionalism and attention to detail
  • Signals you’re ready for the big leagues

Common Biotech Communication Mistakes (And How to Avoid Them)

After creating 400+ animations for biotech companies, we’ve seen patterns in what works and what doesn’t:

Mistake #1: Assuming Scientific Accuracy Requires Complexity
Solution: Use progressive disclosure – start simple, add layers as needed

Mistake #2: Focusing on Features Instead of Benefits
Solution: Always connect your mechanism to patient outcomes

Mistake #3: Using Generic Stock Imagery
Solution: Invest in custom visuals that reflect your unique science

Mistake #4: Neglecting the Emotional Story
Solution: Include patient perspectives and real-world impact

Your Next Steps: Implementing Science Animation for Funding Success

Ready to transform your biotech pitch? Here’s your action plan:

1. Audit Your Current Materials

  • Identify the most complex concepts in your pitch
  • Note where investors typically get confused
  • List the key messages that must come through

2. Prioritize Your Animation Needs

  • Mechanism of action (usually the highest impact)
  • Clinical trial design
  • Competitive differentiation
  • Patient journey

3. Choose the Right Partner

  • Look for experience in your therapeutic area
  • Ensure they balance accuracy with accessibility
  • Check their portfolio for similar complexity levels

4. Measure the Impact

  • Track investor engagement metrics
  • Note changes in meeting dynamics
  • Monitor how often your content gets shared

The Future of Biotech Funding Communications

As the biotech funding landscape becomes increasingly competitive, clear communication isn’t optional – it’s essential. Companies that master science animation for funding will have a significant advantage in:• Attracting top-tier investors

  • Accelerating due diligence processes
  • Building strategic partnerships
  • Ultimately, bringing life-saving therapies to market faster

Turn Your “Huh?” Into Funding Success

Hemab’s $157 million success story shows what’s possible when brilliant science meets clear communication. In today’s competitive funding environment, science animation isn’t just about making pretty pictures – it’s about ensuring your groundbreaking innovation gets the support it deserves.

Whether you’re developing the next breakthrough therapy or seeking your Series A, remember: investors fund what they understand. Make sure they understand yours.